Sign up


Match Document Document Title
8603501 Cancer cell targeting using nanoparticles  
The present invention generally relates to polymers and macromolecules, in particular, to polymers useful in particles such as nanoparticles. One aspect of the invention is directed to a method of...
8603495 Compositions and methods for biological remodeling with frozen particle compositions  
Certain embodiments disclosed herein relate to compositions, methods, devices, systems, and products regarding frozen particles. In certain embodiments, the frozen particles include materials at...
8604072 Treatment using dantrolene  
Provided are low-volume, safe for injection formulations of dantrolene yielding significant advantages over the currently approved and marketed dantrolene for malignant hyperthermia (MH)...
8603496 Compositions and methods for biological remodeling with frozen particle compositions  
Certain embodiments disclosed herein relate to compositions, methods, devices, systems, and products regarding frozen particles. In certain embodiments, the frozen particles include materials at...
8603522 Nutritional supplement to treat macular degeneration  
A daily nutritional or dietary supplement composition that strengthens and promotes retinal health through the prevention, stabilization, reversal and/or treatment of visual acuity loss by reducing...
8603489 Therapeutic proteins from latex  
The invention refers to compositions that comprise the protein preparation, obtained from the latex of Hevea brasiliensis, in a low concentration. Additionally, the invention refers to the use of...
8603566 Cross-linked biopolymers, related compounds and methods of use  
The present invention provides stabilized oil-in-water emulsions with an extended range of chemical, thermal and/or mechanical stabilities, and method(s) for their preparation. Such preparations...
8603500 Cancer cell targeting using nanoparticles  
The present invention generally relates to polymers and macromolecules, in particular, to polymers useful in particles such as nanoparticles. One aspect of the invention is directed to a method of...
8598236 Emulsion system derived from engkabang fat esters  
An isotropic or homogeneous emulsion system comprises an oil phase including fat esters of illipe fat and a solubilizer; a non-ionic surfactants; and deionized water; characterized in that the...
8598233 Method for administering an NMDA receptor antagonist to a subject  
Compositions and methods for administering memantine to a subject are provided. In particular, a solid pharmaceutical composition in a unit dosage form for once daily oral administration is...
8597622 Deodorant cosmetic composition comprising a combination of a lipophilic salicylic acid derivative and an antiperspirant aluminium salt  
The present invention relates to a deodorant cosmetic composition comprising: (a) at least one lipophilic salicylic acid derivative of formula (I) below, or a salt thereof: (b) at least one...
8597642 Tablettable formulations of lipophilic health ingredients  
The present invention is directed to a formulation of a lipophilic health ingredient comprising a lipophilic health ingredient, a protective colloid comprising a modified starch and an emulsifier....
8597932 Cell culture of micorrhizal fungus and arthrobacter histidinolovorans  
The invention involves developing and stabilizing cultivating droplets within a matrix of a porous medium. A cultivation medium may be selected, prepared and mixed with a surfactant. Where cells...
8597666 Compressed solid dosage form manufacturing process well-suited for use with drugs of low aqueous solubility and compressed solid dosage forms made thereby  
A pharmaceutical formulation of compounds with low aqueous solubility and method of manufacture thereof. The formulation may include a pharmacologically active compound having low aqueous...
8592490 Self-microemulsifying drug delivery systems  
Self-microemulsifying drug delivery systems and microemulsions used to enhance the solubility of pharmaceutical ingredients comprising a polyoxyethylene sorbitan fatty acid ester emulsifier; a...
8591922 Gamma-hydroxybutyrate compositions and their use for the treatment of disorders  
Provided herein are pharmaceutical compositions and formulations comprising mixed salts of gamma-hydroxybutyrate (GHB). Also provided herein are methods of making the pharmaceutical compositions...
8591921 Induction of tumor hypoxia for cancer therapy  
Methods and compositions for enhancing the ability of hypoxia-activated bioreductive agents to kill tumor cells within solid tumors are provided. Local regions of hypoxia are created within a...
8591949 Aqueous compositions comprising a chemical microgel associated with an aqueous polymer  
The invention concerns an aqueous composition comprising particles of a water-soluble or water-dispersible chemical microgel, associated with at least a water-soluble or water-dispersible...
8591920 Stable lipophilic emulsions for acrylic coating and method of making  
Emulsions of lipophiles such as glycerol monostearate which are compatible with acrylic copolymer emulsions are made stable by using an emulsion stabilizer such as polysorbate 80 in an amount by...
8591938 Liquid compositions of calcium acetate  
The invention relates to an aqueous liquid composition of calcium acetate, sweetener, and taste masking agent. Also provided is a method for binding phosphorus within the gastrointestinal tract of...
8592480 Liquid compositions of calcium acetate  
The invention relates to an aqueous liquid composition of calcium acetate, sweetener, and taste masking agent. Also provided is a method for binding phosphorus within the gastrointestinal tract of...
8586063 Thickeners  
Disclosed are compounds obtained by reacting (a) epoxides (I) which comprise at least two epoxide groups per molecule, with (b) compounds of the structure (II), having substituents as defined, and...
8586060 Cosmetic or pharmaceutical preparation  
The invention proposes a cosmetic or pharmaceutical preparation containing a mixture of medium-chain, preferably saturated triglycerides with a fatty acid chain length of between C8 and C10 of...
8586705 Macromolecular compounds having controlled stoichiometry  
The following invention is directed to macromolecules having controlled stoichiometry and topology, processes for their production, and applications for their use. The macromolecules have a...
8586061 Multiple unit dosage form having a therapeutic agent in combination with a nutritional supplement  
Compositions and methods for combination therapy are provided. The compositions comprise a multiple unit dosage form having both a therapeutic agent and a nutritional supplement. The combination...
8586082 Solid orally administerable pharmaceutical dosage forms with rapid active principle release  
The present invention relates to solid pharmaceutical dosage forms which can be administered orally and comprise...
8586621 Anti-parasitic methods and compositions utilizing diindolylmethane-related indoles  
The present invention includes methods and compositions for the treatment and prevention of protozoal parasitic infections utilizing Diindolylmethane-related indoles. Additive and synergistic...
8586730 Chirally correct retinal cyclodextrin hemiacetals for clarifying skin complexion  
The present invention discloses certain chirally correct polyene cyclodextrin acetals and hemiacetals (formula I) that are effective in providing skin clarification, which is useful for the...
8586088 Tamper-resistant oral opioid agonist formulations  
Disclosed is an oral dosage form comprising: (i) an opioid agonist in releasable form and (ii) a sequestered opioid antagonist which is not released when the dosage form is administered orally intact.
8586064 Treating eczema and/or psoriasis  
The treatment of humans or other mammals for eczema and/or psoriasis using dosage forms or compositions that include cetyl myristate alone or (in admixture or serially) both cetyl myristate and...
8586062 Nanodispersion  
The present invention provides a nanodispersion comprising nanoparticles having a mean size less than 300 nm dispersed in a vehicle comprising a water miscible solvent and water, said nanoparticles...
8580281 Medicated patch  
Provided is a medicated patch containing a medicinal agent and an adhesive base material and having an acid value of no greater than 28, where the medicinal agent is varenicline or a...
8580296 Pharmacokinetics of S-adenosylmethionine formulations  
Compositions and methods to improve the pharmacokinetic profile of S-Adenosylmethionine (SAMe) are provided, as are methods of treating various disorders using SAMe formulations with improved...
8580856 Acetaminophen/ibuprofen combinations and method for their use  
A pharmaceutical dosage form is provided comprising a non-steroidal anti-inflammatory agent and acetaminophen, and methods for their use. In one embodiment, the dosage form is comprised of...
8580858 Compositions for the treatment of CNS-related conditions  
The invention provides compositions comprising extended release memantine in combination with immediate release donepezil to a subject. Memantine in an extended release form containing 22.5 to 30...
8580779 1,2-bis-sulfonamide derivatives as chemokine receptor modulators  
The present invention relates to novel bis-sulfonamide derivatives, processes for preparing them, pharmaceutical compositions containing them and their use as pharmaceuticals as modulators of...
8580282 Dental anesthetic comprising tetracaine and a vasoconstrictor for intranasal administration  
The present invention relates to tetracaine based anesthetic formulations and methods of use thereof. The invention further relates to topical formulations of tetracaine and methods of topically...
8580846 Use of equol for ameliorating or preventing neuropsychiatric and neurodegenerative diseases or disorders  
The invention is directed to a method of preventing or ameliorating a neuropsychiatric or neurodegenerative disease or disorder in a subject. The method includes administering a composition...
8580830 Non-mucoadhesive film dosage forms  
Orally disintegrating film dosage forms for delivering active pharmaceutical agents, methods of formulating the dosage forms to retard absorption through the oral mucosa, and methods of using the...
8574613 Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof  
A method and device for treating a mammalian organism to obtain a desired local or systemic physiological or pharmacological effect is provided. The method includes administering a sustained...
8574600 Porous particles and cosmetics  
The invention provides porous particles, a process for producing the porous particles, and cosmetics comprising the porous particles. The porous particles of the invention have an average particle...
8574558 UV-curable nail coating formulations based on renewable polyols  
A photopolymerizable composition for forming a cosmetic coating for natural and artificial nails of humans and animals comprising a photoinitiator and a (meth)acrylate monomer prepared by reacting...
8574601 Sustained-release polymer micelle disruptable by HDL  
A pharmaceutical composition containing a drug encapsulated in a polymer micelle composition containing a first block copolymer having affinity with HDL and a second block copolymer having affinity...
8573198 Devices and methods for aerosol therapy using hyperbaric tonometry  
Methods and devices for creating a supersaturated liquid solution having dissolved gas with hyperbaric partial pressures and aerosolizing the supersaturated solution via a nebulizer. High partial...
8574559 Low-residue deodorant or antiperspirant stick based on an oil-in-water dispersion/emulsion  
Deodorant or antiperspirant sticks based on an oil-in-water dispersion/emulsion for application on the skin.
8574622 Controlled release delivery system for nasal applications  
This invention relates to a pernasally administrable preparation for the controlled release of sexual hormones to the systemic circulation, in particular to a formulation which enables its active...
8574628 Natural, multiple release and re-use compositions  
A composition comprising a biopolymer matrix, said biopolymer matrix comprising from about 0.1% to about 40% of an essential oil, about 30% to about 95% of a biopolymer, and about 0% to about 50%...
8574630 Corticosteroid particles and method of production  
A new particle morphology of glucocorticosteroids is described. The forms have a particle morphology that is particularly well suited for use in an inhaled corticosteroid drug suspension...
8568745 Water-soluble drug carrier and process for producing the same  
An object of the present invention is to provide a drug delivery carrier that is free from the drug leakage problem and has an easily controllable particle size, and that can be used to deliver...
8568747 Enalapril compositions  
Provided herein are stable enalapril powder compositions for oral liquid formulation. Also provided herein are methods of using enalapril oral liquid formulations for the treatment of certain...